Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
P1.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
P1.16-06 - Early Changes in Pulmonary Function Are Associated with Development of Pneumonitis in NSCLC Patients Receiving Immune Checkpoint Blockade
09:45 - 09:45 | Presenter: Joshua Reuss | Author(s): Karthik Suresh, Kevin Psoter, Patrick M. Forde, Jarushka Naidoo
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.10 - Peripheral T Cell Repertoire Evolution in Resectable NSCLC Treated with Neoadjuvant PD-1 Blockade
15:05 - 15:10 | Presenter: Justina X Caushi | Author(s): Jiajia Zhang, Zhicheng Ji, Marguerrita El Asmar, Valsamo Anagnostou, Tricia R Cottrell, Hok Yee Chan, Haidan Guo, Taha Merghoub, Jamie E. Chaft, Jedd D Wolchok, Joshua Reuss, Kristen A Marrone, Jarushka Naidoo, Edward Gabrielson, Janis M Taube, Julie R Brahmer, Victor Velculescu, Ni Zhao, Matthew Hellmann, Patrick M. Forde, Drew M Pardoll, Srinivasan Yegnasubramanian, Hongkai Ji, Kellie Smith
- Abstract
Loading...
-
+
ES22 - Immunotherapy - Discovering New Areas
- 15:45 - 17:15
- 9/09/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Educational Session
- Track: Immuno-oncology
- Moderators:Manuel Cobo, Antonio Araujo
-
+
ES22.01 - Immunotherapy in Resectable NSCLC
15:45 - 16:00 | Presenter: Patrick M. Forde
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-07 - Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1-Containing Therapy (HUDSON)
10:15 - 10:15 | Presenter: Si-Houy Lao-Sirieix | Author(s): John Victor Heymach, Patrick M. Forde, Michael Thomas, Keunchil Park, Benjamin Besse, Mark Awad, Glenwood D. Goss, Naiyer A Rizvi, Helen A Ambrose, Wouter Hanekom, Steven Fox, Philip J Jewsbury, Gayle P Pouliot, Peter G Mortimer, Sabina I Patel, Kris Sachsenmeier, J.C Barrett, M Stuart, Z Szucs, L Walton
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-24 - Transcriptional Profiling of Neoantigen Specific T Cells in Resectable NSCLC Treated with Neoadjuvant Anti-PD-1
10:15 - 10:15 | Presenter: Justina X Caushi | Author(s): Zhicheng Ji, Jiajia Zhang, Marguerrita El Asmar, Valsamo Anagnostou, Tricia R Cottrell, Hok Yee Chan, Haidan Guo, Taha Merghoub, Jedd D Wolchok, Jarushka Naidoo, Kristen A Marrone, Jamie E. Chaft, Matthew Hellmann, Edward Gabrielson, Janis M Taube, Julie R Brahmer, Victor E Velculescu, Ni Zhao, Patrick M. Forde, Drew M Pardoll, Hongkai Ji, Srinivasan Yegnasubramanian, Kellie Smith
- Abstract
Loading... -
+
P2.04-28 - NeoCOAST: Neoadjuvant Durvalumab Alone or with Novel Agents for Resectable, Early-Stage (I–IIIA) Non‑Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Rosario Garcia Campelo | Author(s): Patrick M. Forde, Walter Weder, Jonathan D. Spicer, Peng He, Oday Hamid, Pablo Martinez, Tina Cascone
- Abstract
Loading...